Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 130
Filter
1.
J Cardiovasc Surg (Torino) ; 44(6): 681-4, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14735027

ABSTRACT

AIM: The therapeutic mechanism of transmyocardial revascularization (TMR) is not yet fully understood, and continues to be a subject of controversy and active research. Immediate direct laser channel flow, gradual angiogenesis, denervation, and perioperative infarction of the ischemic area have been all discussed, without clear evidence indicating superiority of individual factors. METHODS: We utilized a prospective noninvasive physiologic dynamic method to assess laser-related myocardial injury. The study protocol included EKGs and echocardiograms, including intraoperative transesophageal echocardiograms (TEE) on consecutive TMR patients. CPK-MB was measured postoperatively, with 5 samples at 6-hour intervals. RESULTS: Fifty male patients averaging 62 years old were enrolled in the study. Two patients experienced postoperative myocardial infarctions, from which 1 died. The average CPK-MB values were 12.8+/-1.28 immediately after surgery, 19.2+/-2.4 at 6 h, 15.2+/-2.3 at 12 h, 12.2+/-6.3 at 18 h, and 11.7+/-1.3 at 24 h. In only 5 patients were the CPK-MB values over 30 units at their peak. The intraoperative wall motion remained unchanged in the patients studied, both using TEE and transthoracic echography. CONCLUSION: Significant myocardial injury after TMR appears unlikely, as indicated by CPK-MB and myocardial wall dynamics. Furthermore, TMR does not seem to aggravate baseline myocardial ischemia. We found no evidence to support a hypothesis that surgical myocardial injury constitutes the mechanism of therapeutic action in TMR.


Subject(s)
Angioplasty, Laser/adverse effects , Coronary Disease/surgery , Creatine Kinase/analysis , Echocardiography, Transesophageal/methods , Electrocardiography/methods , Isoenzymes/analysis , Myocardial Reperfusion Injury/diagnosis , Adult , Aged , Angioplasty, Laser/methods , Coronary Disease/diagnosis , Creatine Kinase, MB Form , Humans , Male , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Minimally Invasive Surgical Procedures/methods , Myocardial Ischemia/diagnosis , Myocardial Ischemia/mortality , Myocardial Reperfusion Injury/mortality , Myocardial Revascularization/adverse effects , Myocardial Revascularization/methods , Prognosis , Prospective Studies , Sensitivity and Specificity , Survival Rate
2.
Ann Thorac Surg ; 72(4): 1336-42; discussion 1343, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11603457

ABSTRACT

BACKGROUND: Optimal clinical stimulation for skeletal muscle cardiac assist systems (such as dynamic cardiomyoplasty) is not clearly defined. The pressure-generating capacity of canine skeletal muscle ventricles (SMVs) at a variety of preloads and stimulation frequencies was examined as was time for SMVs to develop peak pressure. METHODS: SMVs were analyzed just after construction and after 3 months of electrical conditioning. Pressure generation and time to develop peak pressure were determined using a distensible mandrel. RESULTS: Higher preloads resulted in increased pressure generation; conditioned SMVs generated significantly less pressure than unconditioned SMVs. Increasing stimulation frequency from 20 to 50 Hz increased pressure-generating capacity; increases beyond 50 Hz did not result in further increases. Time to 90% peak pressure was least at 10 HZ and 65 Hz. CONCLUSIONS: Higher stimulation frequencies and preloads result in a more quickly contracting muscle, which generates more pressure. Midrange stimulation frequencies of 30 Hz provide optimal muscle strength and minimize time to develop peak pressure. Initiation of contraction should begin before the time maximal pressure is desired.


Subject(s)
Cardiomyoplasty , Muscle, Skeletal/physiopathology , Myocardial Contraction/physiology , Animals , Blood Pressure/physiology , Dogs , Heart Rate/physiology , Humans , Models, Cardiovascular , Ventricular Function, Left/physiology
3.
J Cardiovasc Surg (Torino) ; 42(3): 353-7, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11398032

ABSTRACT

BACKGROUND: Transmyocardial revascularization (TMR) is an emerging therapy for coronary artery disease, with 7 years of published clinical research and nearly three years of clinical application. Every report thus far has confirmed that TMR relieves severe angina pectoris. It is primarily an alternative therapy for angina which has been refractory to conventional medical and surgical treatment. Operative mortality of 3% to 10% has been reported. METHODS: Seventy-seven patients were treated with TMR using a Holmium: YAG laser. Admission criteria included severe angina despite high doses of at least two anti-angina medications and nitroglycerin, reversible ischemia by thallium scan, and unsuitability for CABG or angioplasty. Patients had end-stage ischemic heart disease and multiple previous conventional procedures. TMR was performed through small left anterior thoracotomies using a 10.16 cm or less incision. RESULTS: Seventy-five patients recovered from surgery without major complications. One patient (1.3%) died of an autopsy-proven myocardial infarction in the treated region, and two additional patients had a myocardial infarction (4.3%). Four patients had paresis of the left phrenic nerve, as determined by an elevated left hemi-diaphragm on chest X-ray, from which three recovered fully. Patients had no bleeding or wound infections. Patients were intubated for an average of 1.5 hours and remained in ICU an average 0.8 days. Mean hospitalization was 3.4 days. CONCLUSIONS: Technically well-done TMR through a small anterior thoracotomy can have good therapeutic results and low morbidity and mortality. We will describe operative techniques which minimize pain and stress and help to insure surgical success.


Subject(s)
Angina Pectoris/surgery , Coronary Disease/surgery , Laser Therapy/methods , Myocardial Ischemia/surgery , Myocardial Revascularization/methods , Aged , Angina Pectoris/mortality , Coronary Disease/mortality , Female , Humans , Male , Middle Aged , Myocardial Ischemia/mortality , Postoperative Complications/etiology , Postoperative Complications/mortality , Risk Factors , Survival Rate , Thoracotomy/methods
4.
Plant Physiol ; 125(2): 728-37, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11161030

ABSTRACT

Phosphate (Pi) is one of the least available plant nutrients found in the soil. A significant amount of phosphate is bound in organic forms in the rhizosphere. Phosphatases produced by plants and microbes are presumed to convert organic phosphorus into available Pi, which is absorbed by plants. In this study we describe the isolation and characterization of a novel tomato (Lycopersicon esculentum) phosphate starvation-induced gene (LePS2) representing an acid phosphatase. LePS2 is a member of a small gene family in tomato. The cDNA is 942 bp long and contains an open reading frame encoding a 269-amino acid polypeptide. The amino acid sequence of LePS2 has a significant similarity with a phosphatase from chicken. Distinct regions of the peptide also share significant identity with the members of HAD and DDDD super families of phosphohydrolases. Many plant homologs of LePS2 are found in the databases. The LePS2 transcripts are induced rapidly in tomato plant and cell culture in the absence of Pi. However, the induction is repressible in the presence of Pi. Divided root studies indicate that internal Pi levels regulate the expression of LePS2. The enhanced expression of LePS2 is a specific response to Pi starvation, and it is not affected by starvation of other nutrients or abiotic stresses. The bacterially (Escherichia coli) expressed protein exhibits phosphatase activity against the synthetic substrate p-nitrophenyl phosphate. The pH optimum of the enzyme activity suggests that LePS2 is an acid phosphatase.


Subject(s)
Acid Phosphatase/genetics , Acid Phosphatase/metabolism , Phosphates/metabolism , Phosphorus/deficiency , Solanum lycopersicum/enzymology , Acid Phosphatase/biosynthesis , Amino Acid Sequence , Enzyme Induction , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Plant , Solanum lycopersicum/genetics , Molecular Sequence Data , Multigene Family , Sequence Alignment , Sequence Homology, Amino Acid , Transcription, Genetic
6.
Curr Opin Cardiol ; 16(2): 152-7, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11224649

ABSTRACT

This is a review of the current clinical practice and opportunities for quality improvement in aortic valve replacement surgery. The topics include trends and regional variation in procedure rates, and changes in the use of aortic valve replacement among the elderly. Recent developments guiding the choice of prosthetic valves and trends in in-hospital mortality rates for aortic valve surgery are summarized. Lastly, a discussion of topics relevant to clinical practice improvement including the implementation of clinical practice guidelines, the need for consensus on risk adjustment, better understanding of volume-outcome effects, and the opportunities for comprehensive assessment of aortic valve surgery.


Subject(s)
Aortic Valve Insufficiency/surgery , Aortic Valve/transplantation , Heart Valve Prosthesis/trends , Hemodynamics , Humans , Quality of Health Care , Risk Adjustment
7.
Ann Thorac Surg ; 70(4): 1208-11, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11081872

ABSTRACT

BACKGROUND: Using a historical cohort study model, we tested the hypothesis that heterogeneity of emphysematous changes on the preoperative chest radiograph correlated with favorable outcome of lung volume reduction surgery. METHODS: The test population consisted of 21 patients with severe emphysema who were being treated at a 1,000-bed university-affiliated tertiary teaching hospital. A simple but quantitative index of heterogeneity has been devised, whereby the preoperative posteroanterior chest radiographic lung fields are divided into four geometric quadrants. Each quadrant is scored (0 to 4) for emphysematous changes by two radiologists blinded as to subsequent patient management and outcome. Criteria for determining presence of emphysema were hyperlucency, decreased vascular markings, and parenchymal crowding indicating compressed lung. Heterogeneity index is the sum of the two highest scores minus the two lowest, with a maximum index of 8 and a minimum of 0. Preoperative chest radiographs and postoperative changes in forced expiratory volume in 1 second were examined. RESULTS: The heterogeneity index was positively correlated with change in forced expiratory volume in 1 second after operation with an r2 of 0.31 and an average increase of 117 mL per unit increase in heterogeneity index (p < 0.009). CONCLUSIONS: This simple index of heterogeneity may be useful as a predictor of improved pulmonary function after lung volume reduction surgery.


Subject(s)
Forced Expiratory Volume/physiology , Lung/diagnostic imaging , Pneumonectomy/methods , Pulmonary Emphysema/surgery , Total Lung Capacity/physiology , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Postoperative Complications/physiopathology , Predictive Value of Tests , Pulmonary Emphysema/diagnostic imaging , Pulmonary Emphysema/physiopathology , Radiography , Retrospective Studies , Treatment Outcome
8.
J Cardiovasc Surg (Torino) ; 41(2): 165-70, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10901516

ABSTRACT

BACKGROUND: Elderly surgical patients have higher operative morbidity and mortality than younger cohorts, particularly when the procedure is lengthy and complex. While use of bilateral internal thoracic arteries (BITA) is often associated with increased surgical risk, we nevertheless hypothesized that the use of BITA in elderly coronary artery bypass patients would not significantly increase their operative risk beyond that encountered using single internal thoracic arterial (SITA) or saphenous vein grafts (SVG). We maintained that arterial grafts remain essentially unaffected by arteriosclerosis, and that extension of a high-quality life is a desirable outcome regardless of age at operation. EXPERIMENTAL DESIGN: We studied myocardial revascularization in 673 patients over 65 years of age at the time of operation. All operations were conducted or supervised by a single surgeon during a ten-year period from January 1986 to January 1996. Preoperative and operative dates were recorded prospectively. SETTING: All patients underwent coronary artery bypass grafting. INTERVENTIONS: The study compared outcomes in patients having all veins, SITA or BITA operations. For the first analysis, 673 patients were divided into three groups: 163 patients (Group 1) had saphenous vein used for all bypasses; 338 patients had a SITA with supplemental vein grafts (Group 2); and 172 patients (Group 3) had BITAs with additional vein grafts as needed. In the second analysis, Group 3 was subdivided and grouped by the coronary arteries which received the ITA grafts, and the analysis was repeated. One hundred and sixteen patients (Group 3A) underwent traditional placement of ITA bypasses (left ITA to the LAD, right ITA to the RCA); in Group 3B, 56 patients received revascularization of branches of the left coronary artery (left ITA to the circumflex system, right ITA to the LAD). MEASURES: We communicated directly with 90.5% of the patients, their families, or their physicians. The survival status of the remainder was determined through the National Social Security Death Index Network. This allowed us to obtain follow-up longevity data for 100% of the study sample at a mean observation period of 5.03+/-3.1 years with variation between 10.8 years to 2.4 years. RESULTS: A multivariate analysis showed that placement of both ITA grafts to left-sided arteries in older patients independently improved long-term survival (p=0.031). CONCLUSIONS: The BITA procedure does not have greater operative morbidity or mortality in the elderly despite the length or complexity of the surgery. To realize improved long-term survival rates, however, both ITAs must be grafted to the left coronary artery branches.


Subject(s)
Coronary Artery Bypass/methods , Coronary Disease/surgery , Mammary Arteries/transplantation , Aged , Aged, 80 and over , Coronary Artery Bypass/mortality , Coronary Disease/mortality , Female , Humans , Male , Prospective Studies , Risk Factors , Saphenous Vein/transplantation , Survival Rate , Treatment Outcome
10.
Ann Thorac Surg ; 69(3): 967-70, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10750807

ABSTRACT

Aortoesophageal fistula, secondary to thoracic aortic aneurysm, is an uncommon cause of gastrointestinal bleeding that is uniformly fatal without surgical intervention. These may be primary fistulas, in cases of thoracic aortic aneurysm without previous repair, or secondary fistulas occurring after surgical repair of thoracic aortic aneurysm. Surgical treatment has been successful in a small number of cases of primary aortoesophageal fistula, secondary to thoracic aortic aneurysm, but techniques used have varied. We report a successful repair of primary aortoesophageal fistula, secondary to descending thoracic aortic aneurysm, and review the evolution of management since the three previously reported successful repairs at our institution.


Subject(s)
Aortic Aneurysm, Thoracic/complications , Aortic Diseases/surgery , Esophageal Fistula/surgery , Vascular Fistula/surgery , Aorta, Thoracic , Aortic Diseases/etiology , Esophageal Fistula/etiology , Female , Humans , Middle Aged , Vascular Fistula/etiology
11.
J Cardiovasc Surg (Torino) ; 40(5): 627-31, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10596993

ABSTRACT

OBJECTIVE: Despite many technological advances in cardiovascular surgery, some patients still experience postcardiotomy left ventricular (LV) failure that is refractory to both inotropic support and intra-aortic balloon pump (IABP) placement. The primary author (MJR) recently changed from inflow cannulation at the right superior pulmonary vein/left atrial junction to inflow cannulation at the dome of the left atrium. The purpose of this study was to compare data collected during placement of a left ventricular assist device (LVAD) at the junction of the right superior pulmonary vein with positioning the device in the dome of the left atrium. Experimental design, setting, and participants: the medical records of all patients undergoing cardiac surgery by one author (MJR) between 1994 and 1997 were retrospectively reviewed, and 4 patients requiring LVAD placement for short term postcardiotomy support were identified. Each patient's chart was reviewed for duration of LVAD support, average LVAD blood flows, pulmonary capillary wedge pressures (PCWP), preoperative characteristics, postoperative complications, and final outcome for the patients. RESULTS: Accessing the left atrium through the dome resulted in excellent blood flow through the LVAD and allowed for good LV decompression. Hemostasis remained the most common complication regardless of the technique employed; however, the enhanced visibility provided by accessing the left atrium via the dome made repairs less technically difficult. Three patients (75%) were able to be weaned from the LVAD and were discharged from the hospital to home. Two of these patients were cannulated via the left atrial dome making removal of the LVAD easier, thus exposing the patients to less additional operative time. One patient could not be weaned from LVAD support secondary to development of right ventricular failure requiring RVAD insertion and subsequent development of multiple organ failure syndrome. CONCLUSIONS: Patients requiring LV assistance following cardiopulmonary bypass surgery traditionally have high levels of morbidity and mortality. In spite of the complications associated with the placement of an assist device, we remain encouraged by the excellent LV decompression and systemic flows we achieved following implantation of the LVAD through the dome of the left atrium. The superior ease of implantation and decannulation provided better operative care and postoperative management for our patients.


Subject(s)
Counterpulsation/methods , Heart-Assist Devices , Ventricular Dysfunction, Left/therapy , Acute Disease , Aged , Blood Flow Velocity , Cardiac Catheterization , Cardiac Surgical Procedures/adverse effects , Cardiopulmonary Bypass/adverse effects , Humans , Male , Middle Aged , Pulmonary Wedge Pressure , Retrospective Studies , Stroke Volume , Treatment Outcome , Ventricular Dysfunction, Left/etiology , Ventricular Dysfunction, Left/physiopathology
12.
Artif Organs ; 23(6): 504-7, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10392274

ABSTRACT

A totally implantable centrifugal artificial heart has been developed. The plastic prototype, the Gyro PI 601, passed 2 day hemodynamic tests as a functional total artificial heart (TAH), 2 week screening tests for anti-thrombogenecity, and a 1 month system feasibility study. Based upon these results, a metallic prototype, the Gyro PI 700 series, was subjected to long-term in vivo left ventricular assist device (LVAD) studies of over 1 month. The Gyro PI 700 series has the same inner dimension and same characteristics of the Gyro PI 601 such as an eccentric inlet port, a double pivot bearing system, and a magnet coupling system. The PI metallic pump is also driven with the Vienna DC brushless motor actuator like the PI 601. The pump-actuator package was implanted in 3 calves in the preperitoneal space, bypassing from the left ventricular (LV) apex to the descending aorta. Case 1 achieved a 284 day survival. Case 2 was euthanized early at 72 postoperative days as a result of the functional obstruction of the inlet port due to the excessive growth of the calf. There was no blood clot inside the pumps of either case. Case 3 is on-going (22 days on July 24, 1998). During these periods, all cases showed no physiological abnormalities. In conclusion, the PI 700 series pump has excellent results as a long-term implantable LVAD.


Subject(s)
Heart-Assist Devices , Ventricular Function, Left/physiology , Animals , Aorta, Thoracic/surgery , Blood Urea Nitrogen , Body Temperature/physiology , Cattle , Creatinine/blood , Equipment Design , Feasibility Studies , Heart, Artificial , Hemodynamics/physiology , Hemoglobins/analysis , L-Lactate Dehydrogenase/blood , Leukocyte Count , Longitudinal Studies , Magnetics/instrumentation , Metals , Plastics , Surface Properties , Survival Rate , Thrombosis/etiology
13.
Ann Thorac Surg ; 67(6): 1596-601; discussion 1601-2, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10391261

ABSTRACT

BACKGROUND: Transmyocardial revascularization (TMR) surgery uses laser channeling of diseased myocardium to treat ischemia and angina. Rigorous prospective randomized studies have been previously unavailable. METHODS: Forty-three patients were randomized to a medication group and 43 to a group scheduled for TMR surgery and medication. All had advanced cardiac ischemia with CCSA class 3 or 4 angina, took at least 2 cardiac medications at maximum doses, and were ineligible for angioplasty or bypass. RESULTS: Forty-two of 43 TMR group patients received surgery and were discharged after hospitalizations averaging 3.2 days. Two suffered perioperative MIs, with one death. Four others died within 12 months of surgery, 3 from cardiac events and 1 from pneumonia. Five medical group patients died from cardiac events within 12 months. Three, 6, and 12 month exams showed angina class improvement in TMR patients compared to preoperative values (3.86 +/- 0.05 vs 1.71 +/- 0.2, P < 0.0001), and to controls at 12 months (3.77 +/- 0.07 vs 1.71 +/- 0.2, P < 0.0001). Exercise tolerance improved in TMR patients over preoperative values, and was better than medication group scores after 12 months (490 +/- 17 sec. vs 294 +/- 12 sec., p = 0.0002). CONCLUSIONS: Holmium:YAG laser channeling of the myocardium improves function and reduces angina in advanced cardiac patients who lack alternative therapeutic options.


Subject(s)
Angina Pectoris/therapy , Laser Therapy , Myocardial Revascularization/methods , Angina Pectoris/drug therapy , Angina Pectoris/surgery , Exercise Tolerance , Holmium , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome , Yttrium
14.
Ann Thorac Surg ; 67(6): 1793-5, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10391300

ABSTRACT

Because of their anatomic location, cardiac sarcomas often interfere with cardiac function. Excision is considered to palliate the cardiac defect, but complete excision is often difficult owing to access, particularly in left atrial tumors. Incomplete resection results in tumor recurrence. To achieve complete resection of a large left atrial sarcoma, we used the technique of cardiac explantation, extracorporeal resection of the tumor with cardiac reconstruction, and cardiac autotransplantation.


Subject(s)
Heart Neoplasms/surgery , Histiocytoma, Benign Fibrous/surgery , Transplantation, Autologous/methods , Adult , Humans , Male
15.
Curr Opin Cardiol ; 14(2): 79-83, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10191964

ABSTRACT

Methods for analyzing rates of events such as heart valve failure following surgery are important for comparing different techniques and devices; however, in patients undergoing major surgery, other risks such as mortality compete with the risk of heart valve failure to determine each patient's final outcome. When multiple, mutually exclusive endpoints are possible, a situation known to statisticians as a competing risks problem arises. No single statistical technique that is currently available provides an entirely satisfactory solution to this problem. We argue that in order for valve failure incidences to be useful clinically, the overall patient outcome milieu from which these failures arise must be considered. In this article, we review recent work in the area of competing-risks analysis as it pertains to heart valve surgery outcome.


Subject(s)
Actuarial Analysis , Heart Valve Prosthesis Implantation/adverse effects , Heart Valve Prosthesis , Follow-Up Studies , Heart Valve Diseases/surgery , Heart Valve Prosthesis Implantation/mortality , Heart Valve Prosthesis Implantation/statistics & numerical data , Humans , Incidence , Prosthesis Failure , Risk Factors , Survival Rate , Treatment Outcome
17.
Ann Thorac Surg ; 68(6): 2044-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10616974

ABSTRACT

BACKGROUND: The results of pulmonary transplantation are compromised by acute and chronic rejection. We hypothesized that a liposomal form of aerosolized cyclosporine A (CsA) would be selectively deposited and concentrated in the lungs. The theoretical advantage of this therapy is selective pulmonary immunosuppression with prolonged utilization. METHODS: Eighteen dogs were endotracheally intubated; aerosolized liposomal CsA was administered for 15 min. CsA levels were measured in whole blood, lung, trachea, heart, kidney, liver, and spleen at various times after treatment. RESULTS: The lung rapidly absorbs aerosolized liposomal CsA; other organs have much lower concentrations. The retention of pulmonary CsA delivered by liposome aerosol is approximately 120 min in this model. CONCLUSIONS: Aerosolized liposomal CsA is selectively deposited and concentrated in the lungs; other organs absorb less CsA.


Subject(s)
Cyclosporine/pharmacokinetics , Immunosuppressive Agents/pharmacokinetics , Lung Transplantation , Aerosols , Animals , Chromatography, High Pressure Liquid , Cyclosporine/administration & dosage , Dogs , Drug Carriers , Immunosuppressive Agents/administration & dosage , Liposomes , Lung/chemistry , Particle Size , Tissue Distribution
18.
ASAIO J ; 44(5): M619-23, 1998.
Article in English | MEDLINE | ID: mdl-9804509

ABSTRACT

A totally implantable centrifugal artificial heart has been developed. The plastic prototype, Gyro PI 601, passed 2 day hemodynamic tests as a functional total artificial heart, 2 week screening tests for antithrombogenicity, and 1 month system feasibility. Based on these results, a metallic prototype, Gyro PI 702, was subjected to in vivo left ventricular assist device (LVAD) studies. The pump system employed the Gyro PI 702, which has the same inner dimensions and the same characteristics as the Gyro PI 601, including an eccentric inlet port, a double pivot bearing system, and a magnet coupling system. The PI 702 is driven with the Vienna DC brushless motor actuator. For the in vivo LVAD study, the pump actuator package was implanted in the preperitoneal space in two calves, from the left ventricular apex to the descending aorta. Case 1 achieved greater than 9 month survival without any complications, at an average flow rate of 6.6 L/min with 10.2 W input power. Case 2 was killed early due to the excessive growth of the calf, which caused functional obstruction of the inlet port. There was no blood clot inside the pump. During these periods, neither case exhibited any physiologic abnormalities. The PI 702 pump gives excellent results as a long-term implantable LVAD.


Subject(s)
Heart-Assist Devices , Titanium , Equipment Design , Humans , Time Factors
19.
Ann Thorac Surg ; 66(4): 1204-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9800807

ABSTRACT

BACKGROUND: In previous studies of the neurologic outcome of patients undergoing thoracoabdominal aortic aneurysm repair with the simple cross-clamp technique, cross-clamp time of greater than 30 minutes was identified as an important risk factor. We retrospectively examined the effect of clamp time of 30 minutes or greater on outcome for patients undergoing repair with the addition of surgical adjuncts. METHODS: Between February 1991 and June 1996 we operated on 370 patients for thoracoabdominal or descending thoracic aortic aneurysm. Two hundred seventy-one of these patients with cross-clamp times of 30 minutes or greater were included in this study. One hundred twelve patients underwent simple cross-clamp repair, whereas 159 were operated on with the surgical adjuncts of distal aortic perfusion and cerebrospinal fluid drainage. RESULTS: By multivariate analysis, acute dissection, surgical adjuncts, and aneurysm extent proved most significant in overall patient outcome. The overall rate of early neurologic deficits was 23 of 271 (8.5%). For highest risk patients with type II thoracoabdominal aortic aneurysms, the rate of neurologic deficits was 11 of 29 (38%) for cross-clamp versus 6 of 82 (7.3%) for adjunct operation patients (odds ratio = 0.13; p < 0.001). CONCLUSIONS: The adjuncts of cerebrospinal fluid drainage and distal aortic perfusion decreased the risk of extended cross-clamp time during thoracoabdominal aortic aneurysm repair, particularly for highest risk type II.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Paraplegia/epidemiology , Postoperative Complications/epidemiology , Aged , Aortic Aneurysm, Abdominal/classification , Aortic Aneurysm, Thoracic/classification , Constriction , Female , Humans , Intraoperative Care/methods , Male , Paraplegia/etiology , Risk Factors , Time Factors , Treatment Outcome
20.
Ann Thorac Surg ; 66(2): 402-11, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9725376

ABSTRACT

BACKGROUND: We reviewed our experience in the repair of acute and chronic aortic dissection with regard to early neurologic deficit and death. METHODS: Between February 1991 and June 1996, we performed 206 operations on 195 patients for aortic dissection. Ascending or arch repair, or a combination (type A dissection) was performed on 92 of 206 patients (45%); 44 of 92 (48%) were acute dissection and 48 of 92 (52%) were chronic. Descending or thoracoabdominal repair (type B dissection) was performed on 114 of 206 patients (55%); 22 of 114 (19%) were acute and 92 of 114 (81%) were chronic. RESULTS: Among type A cases, strokes occurred in 6 of 92 patients (7%) overall; 4 of 44 (9%) were acute cases and 2 of 48 (4%) were chronic (p < 0.34). Early deaths for type A were 11 of 92 (12%) overall; 9 of 44 (20%) acute and 2 of 48 (4%) chronic (p < 0.02). In type B cases, neurologic complications were 15 of 114 (13%) overall; 7 of 22 (32%) were acute cases and 8 of 92 (9%) were chronic (p < 0.004). Early deaths for type B were 12 of 114 (11%) overall; 3 of 22 (14%) acute and 9 of 92 (10%) chronic (p < 0.6). Preoperative hypotension was significant in acute type A patients, with strokes in 2 of 7 (29%) hypotensives compared with 2 of 37 (5%) normotensives (p < 0.05) and early death in 4 of 7 (57%) hypotensives versus 5 of 37 (14%) normotensives (p < 0.009). CONCLUSIONS: Morbidity and mortality for repair of chronic dissection types A and B were acceptable. Preoperative hypotension in acute type A dissection was a major predisposing factor toward stroke (29% versus 5%, p < 0.05). Acute type B dissection had acceptable mortality (14%) but a high rate of neurologic complications (32%).


Subject(s)
Aortic Aneurysm, Abdominal/mortality , Aortic Aneurysm, Abdominal/surgery , Aortic Aneurysm, Thoracic/mortality , Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/mortality , Aortic Dissection/surgery , Cerebrovascular Disorders/etiology , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Aortic Dissection/complications , Aortic Aneurysm, Abdominal/complications , Aortic Aneurysm, Thoracic/complications , Child , Chronic Disease , Female , Humans , Hypotension/etiology , Male , Methods , Middle Aged , Postoperative Complications , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...